BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Vinod Narayanan – Country President, AstraZeneca Malaysia, together with Dr. Puteri Norliza binti Megat Ramli – Deputy Director, Institut Kanser Negara, at the collaboration announcement

AstraZeneca and Institut Kanser Negara Collaborate to Introduce AI Lung Screening in Malaysia

25 September, 2023 | News

'Bayer For Her' Supporting 365 Days Conversations of Care to More Women in Asia

25 September, 2023 | News

MediLink Therapeutics Focuses on Advancing ADCs for Cancer Treatment

25 September, 2023 | News

Chime Biologics Partners with Panolos Bioscience for Multi-specific Protein Development

25 September, 2023 | News

MicuRx Receives FDA QIDP and Fast Track Designation for Contezolid & Acefosamil

25 September, 2023 | News

Menarini Asia-Pacific and Astellas Sign Exclusive Licensing Deal for Smyraf® in Taiwan and SE Asian Markets

Subject to the terms of the agreement, Astellas will receive total payments of up to €5.5 million including upfront and milestone payments. In addition, Menarini will pay Astellas a high-single digit perce...

Lab

(Seated from left) Dr Jason Chan, Consultant Medical Oncologist & Director of the Cancer Discovery Hub (CDH) at National Cancer Center Singapore and Chow Woai Sheng, Agilent Singapore's General Manager and Vice President of Instrument Manufacturing, (standing from left) Dr Ko Tun Kiat, Lead Scientist at CDH, Cedric Ng, Chief Technology Officer at CDH, Tom Just, Agilent's Vice President of Reagent Partnerships, and Charmian Cher, Agilent's Regional Associate Vice President of Field Marketing.

19 September, 2023 | Tuesday | News

Agilent & NCCS Collaborate to Advance Genomic Profiling in Asian Cancers

The scope of the agreement includes the supply of an Agilent Magnis Next-Generation Sequencing (NGS) Preparation System to help investigate details specific to Asian cancer cohorts, where tissue samples derived...

BioTech

14 September, 2023 | Thursday | News

Singleron Unveils AccuraCode® TCR Kit for Streamlined T-Cell Profiling

The product is built upon Singleron's molecular barcoding technology, enabling multiplexing of 96 or 384 samples in a single library construction reaction. This new product significantly reduces the cost and ti...

Contract Services

25 September, 2023 | Monday | News

Chime Biologics Partners with Panolos Bioscience for Multi-specific Protein Development

Chime Biologics, a leading CDMO that enables biologic therapeutics development announced a strategic cooperation agreement with Panolos Bioscience, a South Korean biotech company to accelerate multi-specific pr...

Consumer Health

25 September, 2023 | Monday | News

'Bayer For Her' Supporting 365 Days Conversations of Care to More Women in Asia

Bayer Pharmaceuticals Division in Asia/Pacific announced in conjunction with World Contraception Day, the inception of its 'Bayer For Her' regional campaign that has been piloted first in Thailan...

White Paper

25 April, 2023 | Tuesday | News

AstraZeneca and Institut Kanser Negara Collaborate to Introduce AI Lung Screening in Malaysia

'Bayer For Her' Supporting 365 Days Conversations of Care to More Women in Asia

MediLink Therapeutics Focuses on Advancing ADCs for Cancer Treatment

Chime Biologics Partners with Panolos Bioscience for Multi-specific Protein Development

MicuRx Receives FDA QIDP and Fast Track Designation for Contezolid & Acefosamil

Menarini Asia-Pacific and Astellas Sign Exclusive Licensing Deal for Smyraf® in Taiwan and SE Asian Markets

Agilent & NCCS Collaborate to Advance Genomic Profiling in Asian Cancers

Singleron Unveils AccuraCode® TCR Kit for Streamlined T-Cell Profiling

Chime Biologics Partners with Panolos Bioscience for Multi-specific Protein Development

'Bayer For Her' Supporting 365 Days Conversations of Care to More Women in Asia

How digitally mature is your QMS?

Agilent & NCCS Collaborate to Advance Genomic Profiling in Asian Cancers

Elevating Energy Efficiency and Sustainability in the Pharmaceutical Industry

Lynk Pharmaceuticals Secures 322 Million RMB in Series C2 Funding

Stay Connected